United Coronary Biobanks (UNICORN)
The UNICORN consists of two collaborating biobanks, one in Utrecht and one in Singapore. From these two sites we include all patients who undergo a coronary catheterization for any reason.
At the moment of catheterization we draw blood, which will be stored in a biobank and we collect clinical characteristics. Patients are followed-up for 5 years for the occurrence of major cardiovascular events.
By including from two sites in the world we include 4 major ethnic groups: Caucasians, Chinese, Indians and Malays. We aim at including at least 2000 patients per ethnic group.
Our hypothesis is that there are differences in the risk factor burden, clinical presentation of CAD, and biochemical patterns in the blood among the ethnic groups.
Furthermore, this biobank offers a platform for multi-ethnic biomarker discovery.
Coronary Artery Disease
Acute Coronary Syndrome
|Study Design:||Observational Model: Cohort
Time Perspective: Prospective
|Official Title:||United CORoNary Biobanks|
- All-cause death [ Time Frame: 5 years ] [ Designated as safety issue: No ]
- Major cardiovascular events [ Time Frame: 5 years ] [ Designated as safety issue: No ]
Biospecimen Retention: Samples With DNA
Plasma, peripheral blood mononuclear cells and whole blood is stored.
|Study Start Date:||September 2010|
|Estimated Study Completion Date:||October 2016|
|Estimated Primary Completion Date:||October 2016 (Final data collection date for primary outcome measure)|
Please refer to this study by its ClinicalTrials.gov identifier: NCT02126150
|Contact: Dominique PV de Kleijn, PhD||+65 email@example.com|
|National University Hospital||Recruiting|
|Singapore, Singapore, 119074|
|Contact: Mark YY Chan, MD +65 6772 5596 firstname.lastname@example.org|